Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

TERCONAZOLE 80 MG SUPPOSITORY

Terconazole
$21.1677per EA

Strength

80 mg/1

Manufacturer

Padagis Israel Pharmaceuticals Ltd

NDC

45802071708

Classification

Generic

Dosage Form

SUPPOSITORY

Route

VAGINAL

Last Updated

4/22/2026

Active Ingredients

TERCONAZOLE

Approval Type

Generic (ANDA)

FDA Application

ANDA077149

On Market Since

8/28/2006

Pharmacological Classes

Azole Antifungal
Azoles

Price History

1W

0.0%

1M

+6.3%

3M

+7.1%

6M

+18.7%

1Y

+8.5%

3Y

-14.1%

5Y

-7.9%

All

-15.0%

Generic Alternatives

1 alternative • Same active ingredient

TERCONAZOLE 80 MG SUPPOSITORY
Generic
00713055273•Cosette Pharmaceuticals, Inc.
$21.1677

Related Drugs

Same classification

ATHLETE'S FOOT 2% POWDER SPRAY
Generic
70000032101•Cardinal Health
$0.0362
per GM
CLOTRIMAZOLE 1% TOPICAL CREAM
Generic
00536126526•Rugby Laboratories
$0.0494
per GM
GNP MICONAZORB AF 2% POWDER
Generic
46122044427•AmerisourceBergen
$0.0579
per GM
GNP MICONAZORB AF 2% POWDER
Generic
46122078929•AmerisourceBergen
$0.0579
per GM
ANTIFUNGAL 2% POWDER
Generic
70000032301•Cardinal Health
$0.0579
per GM
ANTIFUNGAL 2% POWDER
Generic
70000067901•Cardinal Health
$0.0579
per GM
BAZA ANTIFUNGAL 2% CREAM
Generic
11701004514•Coloplast Manufacturing US, LLC
$0.0585
per GM
ATHLETE'S FOOT 1% CREAM
Generic
70000054202•Cardinal Health
$0.0614
per GM
CLOTRIMAZOLE 1% TOPICAL CREAM
Generic
00536126595•Rugby Laboratories
$0.0639
per GM
ANTIFUNGAL 1% TOPICAL CREAM
Generic
00536127222•Rugby Laboratories
$0.0639
per GM

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy